SLC6A1 and Anxiety: Previous research revealed that the selective blocker of GAT-1, tiagabine, increased the levels of GABA in the synaptic cleft in individuals with anxiety [56], suggesting that the impaired functioning of GAT may have resulted in GABA+ increases.